Atlas Trials

Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies

Clinical trial NCT01905813 · COMPLETED

Trial details

NCT number
NCT01905813
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
B-cell Malignancies
Start date
2013-06-30
Primary completion
2026-02-26
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.